Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) Price Target at $5.81

Definitive Healthcare Corp. (NASDAQ:DH) has been given an average rating of “Hold” by the eleven brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $5.81.

Several equities analysts have commented on DH shares. BTIG Research started coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th.

Insider Activity at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 14.84% of the stock is currently owned by company insiders.

Institutional Trading of Definitive Healthcare

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in Definitive Healthcare by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock valued at $36,600,000 after acquiring an additional 67,068 shares during the period. Comerica Bank raised its holdings in Definitive Healthcare by 9.3% during the first quarter. Comerica Bank now owns 436,831 shares of the company’s stock worth $3,525,000 after buying an additional 37,044 shares during the last quarter. Boston Partners bought a new position in shares of Definitive Healthcare in the first quarter valued at $550,000. Valeo Financial Advisors LLC grew its holdings in shares of Definitive Healthcare by 11.8% during the second quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company’s stock valued at $323,000 after buying an additional 6,230 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. bought a new stake in shares of Definitive Healthcare during the second quarter worth about $127,000. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Up 2.0 %

Shares of DH opened at $4.66 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62. The stock has a market capitalization of $538.32 million, a price-to-earnings ratio of -1.50, a PEG ratio of 3.51 and a beta of 1.40. The stock has a fifty day moving average of $4.39 and a 200-day moving average of $4.74.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.